Treatment of Alzheimer's disease: hopes and reality.
The relative failure of symptomatic therapeutic trials for Alzheimer's disease using non-selective cholinergic agonists brings about the need for longitudinal studies with parallel designs aimed at disease stabilization, using trophic substances or amyloid suppressors.
McGill Centre for Studies in Aging, Montreal, Quebec, Canada.
S
S
Gauthier
L
L
Gauthier
R
R
Bouchard
R
R
Quirion
S
S
Sultan
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D010277:Parasympathomimetics / Q000627:therapeutic use*; D011379:Prognosis; D011569:Psychiatric Status Rating Scales; D012107:Research Design; D016896:Treatment Outcome
D010277:Parasympathomimetics